P07.01 P07.02
Conditions
Interventions
Group 1: premature babies.
Before a child is included in the study, the parent or guardian is informed by an investigator using the written information form. The written consent of the parents is obt
Sponsors
Universitätsklinikum Freiburg
Eligibility
Sex/Gender
All
Age
6 Years to 13 Years
Inclusion criteria
Inclusion criteria: All 12 premature babies (6 children in the case group included in the H.E.L.P. Apherese study and the 6 children in the control group.
Exclusion criteria
Exclusion criteria: Lack of consent from the children's carers, as well as a lack of willingness to report the evaluation forms and data to us and, of course, patients who have already died.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.) The review of psychosocial and physical development at the age of 6-7 years of the former premature children of mothers with early preeclampsia who received a lipidapheresis procedure for prolonging pregnancy compared to the control group. 2.) The detection of possible late consequences that may have been caused by the applied maternal therapy. These include endocrinological disorders, respiratory diseases, epilepsy, renal impairment, cerebral palsy and growth delays. The required data is collected by using: questionnaires, clinical examinations, anamnesis, development scores, data from examinations that have already been carried out, Ultrasound First, the survey takes place via questionnaire, these are collected and evaluated and further data are collected during a personal interview. | — |
Secondary
| Measure | Time frame |
|---|---|
| no secondary outcome | — |
Countries
Germany
Contacts
Public ContactKarl Winkler
Insitut für Klinische Chemie und Laboratoriummedizin
Outcome results
None listed